Ranibizumab - CISMeF

Preferred Label : Ranibizumab;

MeSH definition : A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.;

MeSH synonym : RhuFab V2; V2, RhuFab;

MeSH hyponym : lucentis;

MeSH Related Number : 347396-82-1;

Is substance : O;

UNII : ZL1R02VT79;

Details

Origin ID

D000069579;

UMLS CUI

C1566537;

ATC code(s)
- ranibizumab [ATC Code]
ATC code(s)
- ranibizumab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Ranibizumab [NCIt concept]
- Ranibizumab (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Ranibizumab [ICD-11 Extension code]
- Ranibizumab [SMS substance]
- Ranibizumab [Anticorps monoclonal]
- ranibizumab [International Nonproprietary Name]
Exact mapping(s) to DCI
- ranibizumab [International Nonproprietary Name]
Pharmacological action(s)
- angiogenesis inhibitors [MeSH Descriptor]
- immunologic factors [MeSH Descriptor]
Record concept(s)
- lucentis [MeSH concept]
- ranibizumab [MeSH concept]
See also
- vascular endothelial growth factor a [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing ranibizumab (medicinal product) [SNOMED CT concept]
- Uveitis caused by ranibizumab (disorder) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing ranibizumab (medicinal product) [SNOMED CT concept]
- Ranibizumab [NCIt concept]
- Ranibizumab (substance) [SNOMED CT concept]
- ranibizumab [ATC Code]
- ranibizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- ranibizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients